DISCOUNT-ZERTIFIKAT - ASTRAZENECA | Market Closed - Deutsche Boerse AG 15:41:54 2024-05-31 EDT | ||
| 79.77 EUR | +0.01% |
|
| Current month | +0.35% | ||
| 1 month | +0.35% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ASTRAZENECA PLC
Latest news about ASTRAZENECA PLC
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 79.77 | +0.01% |
| 24-05-30 | 79.76 | +0.03% |
| 24-05-29 | 79.74 | +0.01% |
| 24-05-28 | 79.73 | +0.01% |
| 24-05-27 | 79.72 | +0.01% |
Delayed Quote Deutsche Boerse AG
Last update May 31, 2024 at 03:41 pm
More quotesStatic data
| Product type | Discount-Zertifikate |
|---|---|
| Buy / Sell | CALL |
| Underlying | ASTRAZENECA PLC |
| Issuer | 
Société Générale
|
| WKN | SW1JHJ |
| ISIN | DE000SW1JHJ6 |
| Date issued | 2023-07-27 |
| Maturity | 2024-06-21 (21 Days) |
| Parity | 1 : 1 |
| Emission price | 76.5 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 79.82 € |
|---|---|
| Lowest since issue | 76.46 € |
Company Profile
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows:
- product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases);
- collaboration revenue (4.4%).
Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
Consensus: AstraZeneca PLC
Sell
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
155.1
USD
Average target price
172
USD
Spread / Average Target
+10.90%
- Stock Market
- Certificates
- Certificat
